Enduring CME
SCAPA offers online Enduring CME accredited by AAPA. This learn-at-your-own-pace module allows you to watch sessions on your own timeline.
Once you purchase a learning bundle, you will receive an invitation by email to log into the virtual conference portal (this may take up to two business days) where you can view sessions at your leisure. A CME Survey is linked to each session in the “Description” area. You should complete this after viewing each session. Once you have viewed all sessions and completed the CME Survey for each session, you must notify SCAPA by email.
Sessions must be viewed and surveys completed by October 7, 2025, in order to earn credit. As the purchaser, you are responsible for notifying SCAPA that you have completed your courses by the deadline.

Enduring CME Bundle #1: Four Hours Controlled Substance Credits
$50 members/$75 non-members
Enduring CME Bundle #1 is four (4) Controlled Substance Enduring CME Credits. The courses were recorded on October 20, 2024, during SCAPA’s Annual CME Conference.
The AAPA Review Panel has awarded a maximum of 4 AAPA Category I CME credits for this program. Four (4) hours of Controlled Substance credits are included.
Once registered, you will receive an invitation by email to log into the 2024 virtual conference portal (this may take up to 2 business days) where you can view sessions and complete session surveys at your leisure.
Sessions must be viewed by October 7, 2025, to earn credit. You are responsible for contacting SCAPA to report you have completed all courses and surveys before the deadline.
Sessions available for viewing are listed below.
- Controlled Substance: South Carolina Prescribing Laws
Sarah Chapman, PharmD - Controlled Substance: Striking a Balance: Understanding Pain Management and Opioids – Dennis Rivenburgh, MS, ATC, PA-C, DFAAPA – This activity is provided by the American Academy of PAs in collaboration with The Collaboration for REMS Education (CO*RE) and supported by an independent educational grant from the Opioid Analgesics REMS Program Companies (RPC).
- Controlled Substance: Treatment of Overdose – Talisha Ratliff, PharmD
- Controlled Substance: Opioids: Exploring Mechanisms, Effects, and Clinical Applications – Josh Allen, PharmD
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. Approval is valid from 12/10/2024 to 10/7/2025. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-2012697.

2024 Fall CME 25 Credits
$200/members $300/non-members
Enduring CME Bundle #1 is 25 CME credits. The AAPA Review Panel has awarded a maximum of 25 AAPA Category I CME credits for this program. The program also Includes 4 hours of controlled substance and 14 hours of pharmacology. The program includes 4 hours of controlled substance and 14 hours of pharmacology. The courses were recorded from October 16 – October 20, 2024, during SCAPA’s Annual CME Conference.
Once registered, you will receive an invitation by email to log into the 2024 virtual conference portal (this may take up to 2 business days) where you can view sessions and complete session surveys at your leisure.
Sessions must be viewed by October 7, 2025, to earn credit. You are responsible for contacting SCAPA to report you have completed all courses and surveys before the deadline.
Sessions available for viewing are listed below.
- A.A. Today – How Alcoholics Anonymous Cooperates with Medical Professionals– George Lunney
- Common Autoimmune Disorders – Laura McElhaney, DHSc, MHE, PA-C
- Living Your Best Work Life: Building Professional Resilience – Tenelle O. Jones, LMFT, LAC, CIMHP
- Overview of Common Mental Health Disorders in Primary Care – Laura McElhaney, DHSc, MHE, PA-C
- The Heat is On: Hormone Replacement Therapy Updates for 2024 – Breann Garbas, DHSc, PA-C
- Syncope and Dizziness – Making Sense Out of Chaos – John Bielinski, PA-C
- Emerging and Re-emerging Infectious Diseases That Will Impact Your. Practice – Lawrence Herman, DMSC, MPA, PA-C, DFAAPA
- Medical Errors Reduction – John Bielinski, PA-C
- Improving Migraine Management in Primary Care – Kevin Miller, DO – This presentation, provided by Primary Care Education Consortium (PCEC), is supported by an educational grant from Pfizer Inc.
- Pediatric ENT – Byron Mathis, DMSc, PA-C
- The Clot Thickens: Chest Pain and Acute Coronary Syndrome (ACS) –John Bielinski, PA-C
- Update from NCCPA: Focus on the PANRE/PANRE-LA – Alicia Quella, PhD, PA-C
- Aortic Aneurysms – Roll Tide & Hook ’Em Horns – Victor Gomez, PA-C
- Preventing RSV: Providing Older Patients with the Information They Need– Sarah McQueen DMS, PA-C – This AAPA Clinical Case Challenge Series is supported by an independent educational grant from GSK and is being created and managed in collaboration with The France Foundation and the American Thoracic Society.
- Improving the Understanding, Diagnosis, and Management of Generalized Pustular Psoriasis – Leigh Ann Pansch, MSN, FNP-BC, DNCP – This AAPA Clinical Case. Challenge Series is supported by an unrestricted educational grant from Boehringer Ingelheim.
- Bones & Grones Alan Keating, PA-C
- Cirrhosis: A Review for Primary Providers – Sonia Rupani, DMS, M.S. AE-C, PA-C.
- That’s So Renal! A Brief Review of Nephrology – Zachary W. Sutton, DHA, MS, MSPAS, PA-C, DFAAPA, FACHDM
- It’s Not Just A Tremor: A Review Of Parkinson Disease – Sonia Rupani, DMS, M.S. AE-C, PA-C.
- Tackling GERD: History, Myths, & Solutions – Mary Kate Bryant, MD
- Office Based Orthopaedic Evaluation: Head, Shoulders, Knees and Toes – Dennis Rivenburgh, MS, ATC, PA-C,DFAAPA
- Controlled Substance: South Carolina Prescribing Laws – Sarah Chapman, PharmD
- Controlled Substance: Striking a Balance: Understanding Pain Management and Opioids – Dennis Rivenburgh, MS, ATC, PA-C,DFAAPA – This activity is provided by the American Academy of PAs in collaboration with The Collaboration for REMS Education (CO*RE) and supported by an independent educational grant from the Opioid Analgesics REMS Program Companies (RPC)
- Controlled Substance: Treatment of Overdose – Talisha Ratliff, PharmD
- Controlled Substance: Opioids: Exploring Mechanisms, Effects, and Clinical Applications – Josh Allen, PharmD
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 25 AAPA Category 1 CME credits. Approval is valid from 12/2/2024 to 10/7/2025. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-2012201.